Nephrology
IgAN
Expert Roundtables Podcast: Advances and Future Directions in IgA Nephropathy Research
Barratt J, Lafayette RA, Floege J. Therapy of IgA nephropathy: time for a paradigm change. Front Med (Lausanne). 2024;11:1461879. doi:10.3389/fmed.2024.1461879
Cheung CK, Alexander S, Reich HN, Selvaskandan H, Zhang H, Barratt J. The pathogenesis of IgA nephropathy and implications for treatment. Nat Rev Nephrol. 2024 Sep 4;10.1038/s41581-024-00885-3. doi:10.1038/s41581-024-00885-3
Hunter-Dickson M, Wong MG. The role of endothelin receptor antagonists in IgA nephropathy. Nephrology (Carlton). 2024;29(suppl 2):30-33. doi:10.1111/nep.14364
Lim RS, Yeo SC, Barratt J, Rizk DV. An update on current therapeutic options in IgA nephropathy. J Clin Med. 2024;13(4):947. doi:10.3390/jcm13040947
Selvaskandan H, Barratt J, Cheung CK. Novel treatment paradigms: primary IgA nephropathy. Kidney Int Rep. 2023;9(2):203-213. doi:10.1016/j.ekir.2023.11.026
Selvaskandan H, Jhaveri KD, Rizk DV. Primary IgA nephropathy: new insights and emerging therapies. Adv Kidney Dis Health. 2024;31(3):180-193. doi:10.1053/j.akdh.2024.04.002
Suzuki Y. B cell targeting in IgA nephropathy. Nephrology (Carlton). 2024;29(suppl 2):39-43. doi:10.1111/nep.14367